StockData

Clene vs Incannex Healthcare

CLNN and IXHL side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CLNN and IXHL compare

Clene is the larger company, worth 1.9 times as much as Incannex Healthcare ($41.4M against $21.8M).

Incannex Healthcare scores higher on the StockData Score (7 against 1 for Clene), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCLNNIXHL
Size and price
Market cap$41.4M$21.8M
Share price$3.22$1.74
Change, 1 year−62.2%−83.5%
Change, 5 years−96.6%–
Beta (5Y)2.242.40
Employees7912
StockData Score
Total score17 (better)
Valuation score01 (better)
Growth score00
Performance score01 (better)
Health score15 (better)
Dividend score00
Valuation
P/S210×–
P/B–0.3×
FCF yield–−14.6%
Growth
Revenue growth (TTM)−31.1%–
Revenue growth, 5Y average−0.59%–
Profitability
Gross margin70.1%–
Operating margin−10432%–
Net margin−20060%–
Return on equity–−20.7%
Return on invested capital–−1945%
Financial health
Debt / equity–0.00
Interest coverage−7.1×–
Current ratio3.0767.79 (better)
Altman Z-score−21.93−0.22 (better)
Piotroski F-score24 (better)
Dividends and buybacks
Buyback yield–−42.2%
Shareholder yield0.00% (better)−42.2%
Ownership
Held by institutions24.8%3.6%
Held by insiders45.9%–
Insider net buying, 12 months−$5.6M–
Short interest, % of float6.0%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.